A Controlled Study of 4‐[1‐phenyl‐4‐piperazinyl]‐butyl 3,4,5‐trimethoxybenzate hydrochloride (MA 568) and Meprobamate in Psychiatric Outpatients
- 2 January 1965
- journal article
- research article
- Published by Wiley in The Journal of New Drugs
- Vol. 5 (1), 51-56
- https://doi.org/10.1002/j.1552-4604.1965.tb00222.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The Brief Psychiatric Rating ScalePsychological Reports, 1962
- THE SYMPTOMATIC RELIEF OF ANXIETY WITH MEPROBAMATE, PHENOBARBITAL AND PLACEBOAmerican Journal of Psychiatry, 1959
- Comparative effect of phenaglycodol, meprobamate, and a placebo on the irritable colonDigestive Diseases and Sciences, 1959
- A CONTROLLED TRIAL OF MEPROBAMATE IN ANXIOUS OUT-PATIENTSJournal of Neurology, Neurosurgery & Psychiatry, 1958
- A general method of analysis of frequency data for multiple classification designs.Psychological Bulletin, 1957
- Controlled Trial of MeprobamateBMJ, 1956
- USE OF MEPROBAMATE IN THE TREATMENT OF PSYCHOTIC PATIENTSAmerican Journal of Psychiatry, 1956
- A study of hypnotic drugs in patients with chronic diseasesJournal of Chronic Diseases, 1956
- The development of a short form of the Manifest Anxiety Scale.Journal of Consulting Psychology, 1956
- CLINICAL STUDY OF A NEW TRANQUILIZING DRUGJAMA, 1955